Cervical cancer remains a significant global public health issue due to its high incidence and mortality.Current clinical guidelines recommend screening for high-risk human papillomavirus(hrHPV)-DNA alongside a Thinpr...Cervical cancer remains a significant global public health issue due to its high incidence and mortality.Current clinical guidelines recommend screening for high-risk human papillomavirus(hrHPV)-DNA alongside a Thinprep cytologic test(TCT)before further medical evaluation[1].展开更多
基金supported by the National Natural Science Foundation of China(82071651)Chengdu Science and Technology Bureau(2017-GH02-00030-HZ)+4 种基金National Key Research and Development Program of China(2022YFC3600304,2022YFC2704700)Science and Technology Department of Sichuan Province(23ZDYF2489)Sichuan Province Cadre Health Care Scientific Research Project(CGY2023-1701)the Chengdu Technological Innovation R&D Project(2021-YF05-00595-SN)partially sponsored by Lisen Imprinting Diagnostics,Inc.
文摘Cervical cancer remains a significant global public health issue due to its high incidence and mortality.Current clinical guidelines recommend screening for high-risk human papillomavirus(hrHPV)-DNA alongside a Thinprep cytologic test(TCT)before further medical evaluation[1].
